Subsequently, we reported that a functional variant in the VHL target gene CCND1 influenced risk of retinal angiomas and central nervous system hemangioblastomas (but not RCC) in VHL disease patients [11]. The gene discussed is CCND1; the disease is renal cell carcinoma.